researching novel redox regulating therapeutics for the treatment of cancer.

History:

PROLX Pharmaceuticals was acquired by Biomira in 2006.

Employment

Email:

Fax:

Mail:

General Info:

Ticker: private

Employees:

Regions:
Other US

Research Focus:
Disease

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: